Description
SANICARE TBX, when used on environmental, inanimate hard surfaces, exhibits virucidal activity against Hepatitis A Virus (HAV), Poliovirus
Type 1, Canine Parvovirus, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Bovine Viral Diarrhea Virus (BVDV), Human Coronavirus, SARS associated Coronavirus, Avian Influenza A strain H3N2, Avian Influenza A strain H9N2, Paramyxovirus (Mumps), Rhinovirus type 39, Rotavirus, HIV-1 (associated with AIDS), Norovirus (Norwalk virus), Feline Calicivirus, and Rabies Virus. See product label for contact times.
Sanicare TBX kills the following organisms on hard, nonporous inanimate surfaces
BACTERICIDAL ACTIVITY:
Staphylococcus aureus, Salmonella (choleraesuis) enterica, Escherichia coli, Pseudomonas aeruginosa, Escherichia coli 0157:H7, Listeria monocytogenes, Yersinia enterocolitica, Enterococcus faecium, Corynebacterium ammoniagenes, Salmonella (typhi) enterica, and Streptococcus pyogenes.
ANTIBIOTIC-RESISTANT BACTERICIDAL ACTIVITY:
Methicillin resistant Staphylococcus aureus (MRSA); Vanco-mycin intermediate resistant Staphylococcus aureus (VISA); Vancomycin resistant Enterococcus faecalis (VRE); Methicillin resistant Staphylococcus epidermidis (MRSE); Community Associated Methicillin resistant Staphylococcus aureus (CA- MRSA), (NRS 123) Genotype USA400; Community Associ- ated Methicillin resistant Staphylococcus aureus (CA-MRSA), (NRS 384) Genotype USA300.
Available in
•12 x 1 Quart